← Open Payments lookup

LUSINE APIKYAN: Open Payments

NPI 1497176705 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$229 in 10 payments from 7 companies in 2025. Trend: 2023 $507 · 2024 $433 · 2025 $229

Food & beverage: $229
CompanyPaymentsAmount
Novo Nordisk Inc2$61
Amgen Inc.3$47
Aimmune Therapeutics, Inc.1$28
Lilly USA, LLC1$26
PFIZER INC.1$25
DePuy Synthes Sales Inc.1$21
ABBVIE INC.1$20

Products named: OTEZLA, Wegovy, Rybelsus, ZENPEP, ZEPBOUND, ZAVZPRET, EMBOTRAP, QULIPTA.

Industry payments across CA — which companies pay providers there.